European and national policy-makers took a guided tour of Celyad, a clinical-stage biopharmaceutical company specialised in cell-based therapies and recently singled out by the FT. Jointly organised by and EuropaBio, the visit aimed at showing the benefit of advanced therapies in treating patients and raising awareness of the challenges companies face while developing such products.